The purpose of this policy is to identify and manage conflicts of interest of IBC members and consultants that may affect or appear to affect their contributions to protocol review, DURC reviews, or actions to suspend or revoke authorization for previously approved research.
An IBC member or consultant, has a conflict of interest with respect to research when the IBC member or consultant, or an immediate family member:
Except when providing information at the IBC’s request, no IBC member or consultant with a conflict of interest with respect to research may be involved in the review or approval of such research, or in deliberations or voting on actions to suspend, revoke or reinstate authorization for such research. An IBC member may not be counted for quorum in an IBC vote regarding such research.
The UW-Madison Researchers’ Biosafety Manual, UW-Madison, Office of Biological Safety, current version
U.S. Department of Health and Human Services, National Institutes of Health (NIH) - NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, current version and/or any subsequent revisions.
U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) - Biosafety in Microbiological and Biomedical Laboratories (BMBL), Current Edition.